Your Location:
Home >
Browse articles >
Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis
- Military Medical Research Vol. 13, Issue 7, Pages: 1061-1080(2026)
DOI: 10.1186/s40779-026-00686-8
Accepted:30 January 2026
Scan QR Code
Full Text(HTML)
Figs( 8 ) Tabs( 0 )
References
Publication Info
Metrics
35
Views
66
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
An ongoing search for potential targets and therapies for lethal sepsis
Therapeutic effects of anti-endotoxin antibodies and antibiotics on endotoxemia in patients with severe burns
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Endothelial barrier and sepsis: mechanisms and potential therapeutic strategies
Maladaptive reorganization of mediodorsal thalamus as a central mechanism in neuropathic pain-related sleep disorders
Related Author
Guo-Qiang Bao
Li He
David Lee
John D’Angelo
Hai-Chao Wang
Shao-Yu Liu
Shao-Kang Xu
Jing-Li Gao
Related Institution
Department of Emergency Medicine, North Shore University Hospital
The Feinstein Institute for Medical Research, Community Drive
Department of General Surgery, Tangdu Hospital, The 4th Military Medical University
Department of Ophthalmology, University of Alabama at Birmingham
Department of Critical Care Medicine and Hematology, the Second Xiangya Hospital, Central South University

